Menton, France

Paule Bonnet



Average Co-Inventor Count = 7.6

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Breil sur Roya, FR (2011 - 2012)
  • Menton, FR (1995 - 2013)

Company Filing History:


Years Active: 1995-2013

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Paule Bonnet: Innovator in Pharmaceutical Chemistry

Introduction

Paule Bonnet is a distinguished inventor based in Menton, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative patents. With a total of six patents to her name, Bonnet has focused on developing compounds that have important applications in medicine.

Latest Patents

Among her latest patents, one notable invention is the development of 1-N-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them. This invention relates to specific compounds that are defined in the specification, which have potential therapeutic uses. Another significant patent involves indazoles, benzisoxazoles, and benzisothiazoles, which are identified as modulators of estrogen receptors. These compounds are crucial for their role as estrogenic agents, showcasing Bonnet's expertise in creating innovative pharmaceutical solutions.

Career Highlights

Throughout her career, Paule Bonnet has worked with reputable organizations, including Laboratoire Theramex. Her work has been instrumental in advancing pharmaceutical research and development, particularly in the area of estrogen receptor modulation.

Collaborations

Bonnet has collaborated with notable colleagues such as Jean Lafay and Thierry Clerc, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Paule Bonnet's contributions to pharmaceutical chemistry through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to influence the development of important medical compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…